Indication: Leukemia

Risk-stratified Therapy for Acute Myeloid Leukemia in Down Syndrome

Sub-indication: Leukemia

Drug Study

Principal Investigator: Ashok Raj, M.D.
Norton Children's Cancer Institute, affiliated with the UofL School of Medicine

Sponsor: Children's Oncology Group (COG)

Search our entire site.